Kane Biotech Inc.
KNBIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,640 | $7,761 | $14,032 | $15,722 |
| - Cash | $939 | $1,613 | $494 | $359 |
| + Debt | $2,297 | $2,606 | $2,079 | $2,175 |
| Enterprise Value | $8,999 | $8,754 | $15,617 | $17,538 |
| Revenue | $8 | $28 | $413 | $126 |
| % Growth | -69.6% | -93.2% | 227.8% | – |
| Gross Profit | -$5 | -$46 | $42 | -$87 |
| % Margin | -60.3% | -162.6% | 10.3% | -69.3% |
| EBITDA | -$499 | -$197 | -$1,112 | -$957 |
| % Margin | -5,874.3% | -705.3% | -269.6% | -760.3% |
| Net Income | -$607 | -$349 | -$1,218 | -$1,083 |
| % Margin | -7,146.1% | -1,244.9% | -295.4% | -860.4% |
| EPS Diluted | -0.004 | -0.002 | -0.008 | -0.008 |
| % Growth | -71.4% | 74.1% | -2.5% | – |
| Operating Cash Flow | -$698 | -$773 | -$1,104 | -$420 |
| Capital Expenditures | -$6 | -$50 | -$45 | -$41 |
| Free Cash Flow | -$704 | -$823 | -$1,149 | -$461 |